Journal of Clinical Immunology

, Volume 32, Issue 3, pp 604–610 | Cite as

Influence of Maternal Hyperglycemia on IL-10 and TNF-α Production: The Relationship with Perinatal Outcomes

  • Jusciele Brogin Moreli
  • Glilciane Morceli
  • Ana Karina C. De Luca
  • Claudia G. Magalhães
  • Roberto A. A. Costa
  • Débora Cristina Damasceno
  • Marilza Vieira Cunha Rudge
  • Iracema Mattos Paranhos Calderon



This study was conducted to evaluate maternal and placental concentrations of interleukin 10 (IL-10) and tumor necrosis factor-alpha (TNF-α) in pregnant women with glycemic mean (GM) < or ≥100 mg/dL, as well as correlate IL-10 and TNF-α placental concentrations with perinatal outcomes.


One hundred eighty-six pregnant women were distributed in groups determined by a GM <100 mg/dL or a GM ≥100 mg/dL. The GM, HbA1c levels, maternal and placental concentrations of IL-10 and TNF-α, and the correlation of placental cytokines with perinatal outcomes were evaluated.


In maternal blood, the lowest concentrations of IL-10 (p = 0.0019) and TNF-α (p = 0.0185) were observed in the GM ≥100-mg/dL group. The placentas from GM ≥100 mg/dL group exhibited higher TNF-α concentrations (p = 0.0385). Placental IL-10 directly correlated with hemoglobin (r = 0.63; p = 0.02) and insulin (r = 0.78; p = 0.01) levels in the umbilical cord and with 1-min (r = 0.53; p = 0.0095) and 5-min (r = 0.69; p = 0.0003) Apgar scores. Placental TNF-α displayed a tendency to inversely correlate with fetal weight (r = −0.41; p = 0.05).


Compared to GM <100 mg/dL, GM ≥100 mg/dL was associated with a reduction in maternal IL-10 and TNF-α concentrations and increased placental TNF-α production. Placental IL-10 production was similar in both groups studied and directly correlated with hemoglobin and umbilical cord insulin levels, as well as with the 1- and 5-min Apgar scores.


Cytokines diabetes mild gestational hyperglycemia placenta perinatal outcomes 


  1. 1.
    American Diabetes Association (ADA). Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34 Suppl 1:S62–9.CrossRefGoogle Scholar
  2. 2.
    Rudge MV, Calderon IM, Ramos MD, Abbade JF, Rugolo LM. Perinatal outcome of pregnancies complicated by diabetes and by maternal daily hyperglycemia not related to diabetes. A retrospective 10-year analysis. Gynecol Obstet Invest. 2000;50:108–12.PubMedCrossRefGoogle Scholar
  3. 3.
    Eriksson UJ, Cederberg J, Wentzel P. Congenital malformations in offspring of diabetic mothers—animal and human studies. Rev Endocr Metab Disord. 2003;4:79–93.PubMedCrossRefGoogle Scholar
  4. 4.
    Rudge MVC, Calderon IMP, Ramos MD, Brasil MAM, Rugolo LMSS, Bossolan G, et al. Hiperglicemia materna diária diagnosticada pelo perfil glicêmico: um problema de saúde pública materno e perinatal. Rev Bras Ginecol Obstet. 2005;27:691–7.Google Scholar
  5. 5.
    Yang J, Cummings EA, O’Connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol. 2006;108:644–50.PubMedCrossRefGoogle Scholar
  6. 6.
    Calderon IMP, Kerche LTRL, Damasceno DC, Rudge MVC. Diabetes and pregnancy: an update of the problem. ARBS. 2007;9:1–11.Google Scholar
  7. 7.
    Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;333:1–6.CrossRefGoogle Scholar
  8. 8.
    Hod M, Haroush AB, Yogev Y. Pathogenesis of gestational diabetes mellitus. In: Hod M, Jovanovic L, Leiva GCRA, Langer O, editors. Textbook of diabetes and pregnancy. London: Informa Healthcare; 2003. p. 39–49.Google Scholar
  9. 9.
    Vela-Huerta MM, San Vicente-Santoscoy EU, Guizar-Mendoza JM, Amador-Licona N, Aldana-Valenzuela C, Hernnandez J. Leptin, insulin, and glucose serum levels in large-for-gestational-age infants of diabetic and non-diabetic mothers. J Pediatr Endocrinol Metab. 2008;21:17–22.PubMedCrossRefGoogle Scholar
  10. 10.
    International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–82.CrossRefGoogle Scholar
  11. 11.
    Metzger E, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. The HAPO Study Cooperative Research Group. N Engl J Med. 2008;358:1991–2002.PubMedCrossRefGoogle Scholar
  12. 12.
    Rudge MVC, Peraçoli JC, Berezowski AT, Calderon IMP, Brasil MAM. The oral glucose tolerance test is a poor predictor of hyperglycemia during pregnancy. Braz J Med Biol Res. 1990;23:1079–89.PubMedGoogle Scholar
  13. 13.
    Bjork O, Persson B. Villous structure in different parts of the cotyledon in placentas of insulin-dependent diabetic women. A morphometric study. Acta Obstet Gynecol Scand. 1984;63:37–43.PubMedCrossRefGoogle Scholar
  14. 14.
    Taricco E, Radaelli T, Nobile de Santis MS, Cetin I. Foetal and placental weights in relation to maternal characteristics in gestational diabetes. Placenta. 2003;24:343–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Calderon IM, Damasceno DC, Amorin RL, Costa RA, Brasil MA, Rudge MV. Morphometric study of placental villi and vessels in women with mild hyperglycemia or gestational or overt diabetes. Diabetes Res Clin Pract. 2007;78:65–71.PubMedCrossRefGoogle Scholar
  16. 16.
    Sgarbosa F, Barbisan LF, Brasil MAM, Costa E, Calderon IMP, Gonçalves CR, et al. Changes in apoptosis and Bcl-2 expression in human hyperglycemic, term placental trophoblast. Diabetes Res Clin Pract. 2006;73:143–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Pietro L, Daher S, Rudge MV, Calderon IM, Damasceno DC, Sinzato YK, et al. Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women. Placenta. 2010;3:7707–80.Google Scholar
  18. 18.
    Carvalho Silva SAL. Dopplervelocimetria da artéria umbilical como marcador de alterações imunológicas placentárias e de risco de morte perinatal em gestações complicadas por diabete ou hiperglicemia leve [tese]. Faculdade de medicina (Botucatu): Universidade Estadual Paulista; 2010.Google Scholar
  19. 19.
    Thaxton JE, Sharma S. Interleukin-10: a multi-faceted agent of pregnancy. Am J Reprod Immunol. 2010;63:482–91.PubMedCrossRefGoogle Scholar
  20. 20.
    Coughlan MT, Oliva K, Georgiou HM, Permezel JM, Rice GE. Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med. 2001;18:921–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51:2207–13.PubMedCrossRefGoogle Scholar
  22. 22.
    Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol. 1989;46:111–47.PubMedCrossRefGoogle Scholar
  23. 23.
    Negrato CA, Jovanovic L, Tambascia MA, Calderon Ide M, Geloneze B, Dias A, et al. Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Diabetes Metab Res Rev. 2008;24:324–30.PubMedCrossRefGoogle Scholar
  24. 24.
    Rudge MVC, Calderon IMP, Ramos MD, Maestá I, Souza LMS, Peraçoli JC. Perspectiva perinatal decorrentes do rígido controle pré-natal em gestações complicadas pelodiabete. Rev Bras Ginecol Obstet. 1995;17:26–32.Google Scholar
  25. 25.
    Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2000;11:212–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Montazeri S, Nalliah S, Radhakrishnan AK. Is there a genetic variation association in the IL-10 and TNF alpha promoter gene with gestational diabetes mellitus? Hereditas. 2010;147:94–102.PubMedCrossRefGoogle Scholar
  27. 27.
    Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care. 2007;30:S121–6.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Jusciele Brogin Moreli
    • 1
  • Glilciane Morceli
    • 1
  • Ana Karina C. De Luca
    • 2
  • Claudia G. Magalhães
    • 2
  • Roberto A. A. Costa
    • 2
  • Débora Cristina Damasceno
    • 1
    • 2
  • Marilza Vieira Cunha Rudge
    • 1
    • 2
  • Iracema Mattos Paranhos Calderon
    • 1
    • 2
  1. 1.Post-graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical SchoolUNESP—São Paulo State UniversityBotucatuBrazil
  2. 2.Department of Obstetrics and Gynecology, Botucatu Medical SchoolUNESP—São Paulo State UniversityBotucatuBrazil

Personalised recommendations